QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions 期刊论文 ANGIOLOGY, 2019, 卷号: 70, 期号: 3 作者:  Li, Chenguang;  Shen, Yi;  Xu, Rende;  Dai, Yuxiang;  Chang, Shufu 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 coronary chronic total occlusion (CTO)  platelet-to-lymphocyte ratio (PLR)  neutrophil-to-lymphocyte ratio (NLR)  in-stent restenosis (ISR)   Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease: A systematic review and meta-analysis 期刊论文 2019, 卷号: 59, 页码: 112-118 作者:  Ye, Gengfan;  Yin, Xiaoliang;  Yang, Ximeng;  Wang, Junjie;  Qi, Peng 收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03 Drug-eluting stent (DES)  Intracranial atherosclerotic disease (ICAD)  In-stent restenosis (ISR)  Ischemic stroke   Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention 期刊论文 2018, 卷号: 97, 期号: 17 作者:  Liu, Junfeng;  Liu, Yunde;  Jia, Kegang;  Huo, Zhixiao;  Huo, Qianyu 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 in-stent restenosis (ISR)  lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1)  percutaneous coronary intervention (PCI)